BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 21079577)

  • 41. Implication of miRNA in the diagnosis and treatment of breast cancer.
    Castañeda CA; Agullo-Ortuño MT; Fresno Vara JA; Cortes-Funes H; Gomez HL; Ciruelos E
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1265-75. PubMed ID: 21916580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
    Gorenchtein M; Poh CF; Saini R; Garnis C
    J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
    Lim WK; Micklem G
    Mol Biosyst; 2011 Sep; 7(9):2571-6. PubMed ID: 21766137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inferring coregulation of transcription factors and microRNAs in breast cancer.
    Wu JH; Sun YJ; Hsieh PH; Shieh GS
    Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
    Gao W; Xu J; Shu YQ
    Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD.
    Leidinger P; Keller A; Borries A; Huwer H; Rohling M; Huebers J; Lenhof HP; Meese E
    Lung Cancer; 2011 Oct; 74(1):41-7. PubMed ID: 21388703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients.
    Sakurai M; Masuda M; Miki Y; Hirakawa H; Suzuki T; Sasano H
    Int J Biol Markers; 2015 May; 30(2):e190-9. PubMed ID: 25907662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells].
    Zhang H; Su SB; Zhou QM; Lu YY
    Ai Zheng; 2009 May; 28(5):493-9. PubMed ID: 19624877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The oncogenic role of miR-155 in breast cancer.
    Mattiske S; Suetani RJ; Neilsen PM; Callen DF
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1236-43. PubMed ID: 22736789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs in cancer management and their modulation by dietary agents.
    Karius T; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA in colorectal cancer: from benchtop to bedside.
    Wu WK; Law PT; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
    Carcinogenesis; 2011 Mar; 32(3):247-53. PubMed ID: 21081475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel panel of microRNAs provides a sensitive and specific tool for the diagnosis of breast cancer.
    Luo J; Zhao Q; Zhang W; Zhang Z; Gao J; Zhang C; Li Y; Tian Y
    Mol Med Rep; 2014 Aug; 10(2):785-91. PubMed ID: 24866395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability analysis of liver cancer-related microRNAs.
    Li Y; Jiang Z; Xu L; Yao H; Guo J; Ding X
    Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):69-78. PubMed ID: 21173058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.